0001656472-24-000074.txt : 20240528
0001656472-24-000074.hdr.sgml : 20240528
20240528173247
ACCESSION NUMBER: 0001656472-24-000074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240525
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weigensberg Arye
CENTRAL INDEX KEY: 0001937121
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38403
FILM NUMBER: 24993215
MAIL ADDRESS:
STREET 1: 111 PETER STREET, SUITE 300
CITY: TORONTO
STATE: A6
ZIP: MV5 2H1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cronos Group Inc.
CENTRAL INDEX KEY: 0001656472
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
BUSINESS PHONE: (416) 504-0004
MAIL ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaCan Capital Corp.
DATE OF NAME CHANGE: 20151021
4
1
wk-form4_1716931958.xml
FORM 4
X0508
4
2024-05-25
0
0001656472
Cronos Group Inc.
CRON
0001937121
Weigensberg Arye
111 PETER STREET, SUITE 300
TORONTO
A6
M5V 2H1
ONTARIO, CANADA
0
1
0
0
See Remarks
0
COMMON SHARES
2024-05-25
4
M
0
3972
0
A
65197
D
RESTRICTED STOCK UNITS
2024-05-25
4
M
0
3972
0
D
COMMON SHARES
3972
134784
D
Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc.
The RSUs vested in three substantially equal annual installments beginning May 25, 2022, subject to continued employment through each applicable vesting date.
Senior Vice President, Head of Research and Development
/s/ Aaron B. Werner, as attorney-in-fact for Arye Weigensberg
2024-05-28